FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($1.15), $0.18 worse than the analyst estimate of ($0.97). Revenue for the quarter came in at $3.03 million versus the consensus estimate of $5.65 million.
In the second quarter, despite persistent global challenges due to the COVID-19 pandemic,... More

